BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 24268860)

  • 1. Author reply: To PMID 23582989.
    Tse DT; Kossler AL; Feuer WJ; Benedetto PW
    Ophthalmology; 2014 Jan; 121(1):e8-e10. PubMed ID: 24268860
    [No Abstract]   [Full Text] [Related]  

  • 2. Adenoid cystic carcinoma of the lacrimal gland: rare … lethal … cured?
    Bradley EA; Bradley DJ
    Ophthalmology; 2013 Jul; 120(7):1311-2. PubMed ID: 23823505
    [No Abstract]   [Full Text] [Related]  

  • 3. Does intra-arterial chemotherapy improve survival for lacrimal gland adenoid cystic carcinoma?
    Esmaeli B
    Ophthalmology; 2014 Jan; 121(1):e7-e8. PubMed ID: 24268857
    [No Abstract]   [Full Text] [Related]  

  • 4. Disease recurrence after intraarterial chemotherapy in 2 patients with adenoid cystic carcinoma of lacrimal gland.
    Fellman M; Carter K; Call CB; Esmaeli B
    Can J Ophthalmol; 2013 Apr; 48(2):e17-8. PubMed ID: 23561610
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term outcomes of neoadjuvant intra-arterial cytoreductive chemotherapy for lacrimal gland adenoid cystic carcinoma.
    Tse DT; Kossler AL; Feuer WJ; Benedetto PW
    Ophthalmology; 2013 Jul; 120(7):1313-23. PubMed ID: 23582989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-arterial Chemotherapy for Lacrimal Gland Adenoid Cystic Carcinoma.
    Zhang M; Fathy C; Breazzano MP; Hollar M; Barahimi B
    Int Ophthalmol Clin; 2017; 57(1):143-152. PubMed ID: 27898620
    [No Abstract]   [Full Text] [Related]  

  • 7. Intra-arterial chemotherapy: a welcome new idea for the management of adenocystic carcinoma of the lacrimal gland.
    Goldberg RA
    Arch Ophthalmol; 1998 Mar; 116(3):372-3. PubMed ID: 9514492
    [No Abstract]   [Full Text] [Related]  

  • 8. Pediatric adenoid cystic carcinoma of the lacrimal gland treated with intra-arterial cytoreductive chemotherapy.
    Eneh A; Parsa K; Wright KW; Strube YN
    J AAPOS; 2015 Jun; 19(3):272-4. PubMed ID: 25890838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant chemotherapy in lacrimal gland adenoid cystic carcinoma.
    Meel R; Pushker N; Bakhshi S
    Pediatr Blood Cancer; 2009 Dec; 53(6):1163-4. PubMed ID: 19743515
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical analysis of the effect of intraarterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma.
    Tse DT; Benedetto P; Dubovy S; Schiffman JC; Feuer WJ
    Am J Ophthalmol; 2006 Jan; 141(1):44-53. PubMed ID: 16386975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant intracarotid chemotherapy for treatment of advanced adenocystic carcinoma of the lacrimal gland.
    Meldrum ML; Tse DT; Benedetto P
    Arch Ophthalmol; 1998 Mar; 116(3):315-21. PubMed ID: 9514484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of ribosomal protein L39-L in the drug resistance mechanisms of lacrimal gland adenoid cystic carcinoma cells.
    Ye Q; Ding SF; Wang ZA; Feng J; Tan WB
    Asian Pac J Cancer Prev; 2014; 15(12):4995-5000. PubMed ID: 24998577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome Sequencing and Apoptotic Markers to Assess Treatment Response of Lacrimal Gland Adenoid Cystic Carcinoma to Intra-Arterial Cytoreductive Chemotherapy.
    Yu MD; Men CJ; Do H; Colevas AD; Lin JH; Egbert PR; Tse DT; Kossler AL
    Ophthalmic Plast Reconstr Surg; 2022 Mar-Apr 01; 38(2):e44-e47. PubMed ID: 34798653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Case of a bilateral MALT lymphoma of the lacrimal sac treated only medically].
    Abdelkhalek R; Ahmimech J; Mouzariae Y; El Idrissi A; El Hamichi S; Messaoudi R; Bargach T; Reda K; Oubaaz A
    J Fr Ophtalmol; 2015 Dec; 38(10):e237. PubMed ID: 26616299
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of chemotherapy and molecularly targeted agents in the treatment of adenoid cystic carcinoma of the lacrimal gland.
    Le Tourneau C; Razak AR; Levy C; Calugaru V; Galatoire O; Dendale R; Desjardins L; Gan HK
    Br J Ophthalmol; 2011 Nov; 95(11):1483-9. PubMed ID: 21183517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microdissection genotyping analysis of the effect of intraarterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma.
    Tse DT; Finkelstein SD; Benedetto P; Dubovy S; Schiffman J; Feuer WJ
    Am J Ophthalmol; 2006 Jan; 141(1):54-61. PubMed ID: 16386976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Neoadjuvant Intra-arterial Chemotherapy in Lacrimal Gland Adenoid Cystic Carcinoma: A Histological Correlation Using Apoptotic Tumor Markers.
    Maniar A; Saqi A; Troob SH; Belinsky I; Charles NC; Gobin YP; Marr BP
    Ophthalmic Plast Reconstr Surg; 2022 Jan-Feb 01; 38(1):e28-e33. PubMed ID: 34652309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and microdissection genotyping analyses of the effect of intra-arterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma.
    Tse DT
    Trans Am Ophthalmol Soc; 2005; 103():337-67. PubMed ID: 17057810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of cyclophosphamide, doxorubicin, and cisplatin for adenoid cystic carcinoma, and their relationship with the pre-chemotherapy tumor growth rate.
    Ha H; Keam B; Ock CY; Heo DS
    Chin Clin Oncol; 2020 Apr; 9(2):15. PubMed ID: 32366107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclophosphamide, doxorubicin, and cisplatin in advanced salivary gland cancer.
    Debaere D; Vander Poorten V; Nuyts S; Hauben E; Schoenaers J; Schöffski P; Clement PM
    B-ENT; 2011; 7(1):1-6. PubMed ID: 21563549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.